Updates on Novel Erythropoiesis-Stimulating Agents: Clinical and Molecular Approach
Autor: | Mohamad Ahmadi, Mehdi Azad, Javad Sadeghi Shad, Zahra Moradi, Reza Kouchaki, Amirhosein Maali, Alireza Farasat, Mona Moghadami |
---|---|
Rok vydání: | 2019 |
Předmět: | |
Zdroj: | Indian J Hematol Blood Transfus |
ISSN: | 0971-4502 |
Popis: | Erythropoietin (EPO) is an important hormone responsible for the stimulation of hematopoiesis which is impaired in a variety of diseases, such as chronic kidney disease, cancer chemotherapy, and the use of some anti-HIV drugs. Difficulties in the purification of endogenous EPO due to problems such as technical limitations, heterogeneity of target cells, inadequate amount and immunogenicity of the resultant product, had limited the entry of endogenous EPO in the clinical applications. The integration of medical biotechnology and hematology has introduced novel procedures for the production of human recombinant erythropoietin (rHuEPO), and other erythropoiesis-stimulating agents (ESAs). To investigate and produce rHuEPO, the first step is to recognize the molecular biology and functional pathways, structure, metabolism, and basic physiology of EPO. In this review, all clinical indications, side effects, challenges and notable points regarding EPO, rHuEPO, and other ESAs have also been addressed along with its molecular characterization, such as the modifications needed to optimize their rHuEPO biosynthesis. |
Databáze: | OpenAIRE |
Externí odkaz: |
načítá se...